Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats… - Therapeutic …, 2018 - journals.sagepub.com
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats… - Therapeutic …, 2018 - pubmed.ncbi.nlm.nih.gov
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
[PDF][PDF] Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats, T García-Berrocoso, J Montaner - 2018 - scienceopen.com
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
[PDF][PDF] Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats, T García-Berrocoso, J Montaner - 2018 - academia.edu
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats Oriol, T García-Berrocoso… - 2018 - recercat.cat
Altres ajuts: The author (s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: The Neurovascular Research …
research, authorship, and/or publication of this article: The Neurovascular Research …
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management.
L Ramiro, A Simats, T García-Berrocoso… - Therapeutic Advances …, 2018 - europepmc.org
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
[HTML][HTML] Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats, T García-Berrocoso… - Therapeutic Advances …, 2018 - ncbi.nlm.nih.gov
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
L Ramiro, A Simats Oriol, T García-Berrocoso… - Therapeutic Advances …, 2018 - ddd.uab.cat
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management.
L Ramiro, A Simats, T García-Berrocoso… - Therapeutic Advances …, 2018 - europepmc.org
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide.
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …
Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to …